Hospital Pharmacy presents a new feature to keep pharmacists abreast of new publications in the medical/pharmacy literature. Articles of interest will be abstracted monthly regarding a broad scope of topics.
Get full access to this article
View all access options for this article.
References
1.
CromerB.A., LazebnikR., RomeR., StagerM.Double blinded randomized controlled trial of estraogen supplementation in adolexcent girls who received depot medroxyprogesterone acetate for contraception. Am J Obstet Gyencol.2005; 192(1) Jan: 42–47.
2.
SowersJ.R., WhiteW.B., PittB., WheltonA.The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, ostesoarthritis, and type 2 diabetes mellitus. Arch Intern Med.2005; 165(Jan 24):161–168.
3.
SharyaF.T., BlumeS.W., BlanchetteC.M., WeitM.R.Selective cyclooxygenase-2 inhibition and cardiovascular effects. An observational study of a Medicaid population. Arch Intern Med.2005; 165(Jan 24):181–86.
4.
JankaH.U., PleweG., RiddleM.C.Comparison of basal insulin added to oral agents versus twice daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care.2005; 28(2): Feb: 254–59.
De JongheB., Bastuji-GarinS., FangioP., LacheradeJ.C.Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med.2005; 33(1)Jan: 120–127.
7.
GreenC., ColquittJ.L., KirbyJ., DavidsonP.Topical corticosteroids for atopic eczema: clinical cost effectiveness of once daily vs more frequent use. Br J Dermatology.2005; 152(Feb): 130–141.
8.
HafeezA., MehmoodG., MazharF.Oral zinc supplementation in pregnant women and its effect on birth weight: a randomised controlled trial. Arch Dis Child Fetal Neonatal.2005; 90(Feb): F170–F171.
9.
BoyerE.W., ShannonM., HibberdP.L.The internet and psychoactive substance use among innovative drug usersPediatrics2005; 115(2): Feb: 302–305
10.
McMahonA.W., IskanderJ., HaberP., ChangS.Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990–2003. Pediatrics.2005; 115(Feb):453–460.
11.
SinkK.M., HoldenK.F., YaffeK.Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. JAMA.2005; 293(Feb 2):596–608.
12.
GibbonsR.D., JurK., BhaumikD.K., MannJ.J.The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry.2005; 62(Feb):165–172.
SmythA., TanK.H.V., Hyman-TaylorP., MulheranM.Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis – the TOPIC study: a randomised controlled trialLancet.2005; 365(Feb 12):573–578.
15.
SchleinitzM.D., HeidenreichP.A.A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: Clopidogrel plus aspirin versus aspirin alone. Ann Intern Med.2005; 142(4)Feb 15:251–259.
16.
SanzE.J., De-las CuevasC., KiuruA.Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis. Lancet.2005; 365(Feb 5):482–87.
17.
SolomonS.D., McMurrayJ.J.V., PfefferM.A., WittesJ.Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med.2005; 352(Feb 15) http://content.nejm.org/cgi/content/abstract/NEJMoa050405
